Delayed second COVID-19 vaccine dose may not limit efficacy: Studies

Data has continued to accumulate suggesting the UK’s controversial decision to delay the second dose of COVID-19 vaccination may have been a reasonable one. Still, debate does remain over the use of a dosing strategy unsupported by solid clinical trial evidence. Public Health England has said that early data from the SIREN study “shows a ...

Already a member?

Login to keep reading.

© 2021 the limbic